N01.3
Rapidly progressive nephritic syndrome with diffuse mesangial proliferative glomerulonephritis
Clinical Classification Guidelines
Medical Intelligence & Overview
Rapidly progressive nephritic syndrome (RPS) with diffuse mesangial proliferative glomerulonephritis is a serious kidney condition characterized by rapid deterioration of kidney function due to inflammation of the glomeruli, the tiny filtering units within the kidneys. This condition often progresses swiftly, potentially leading to kidney failure if not diagnosed and treated promptly. It involves the proliferation of mesangial cells within the glomeruli, causing impaired filtration and symptoms like hematuria, proteinuria, and swelling.
Causes & Symptoms
Clinical Causes: Autoimmune diseases, such as systemic lupus erythematosus Infections, including post-infectious glomerulonephritis Certain drugs or toxins that trigger immune responses Underlying unknown factors that lead to immune system dysfunction Genetic predispositions may also contribute
Key Symptoms: Blood in the urine (hematuria) Foamy or dark urine due to protein leakage Swelling in the legs, ankles, or around the eyes (edema) High blood pressure Fatigue and weakness Reduced urine output in advanced cases Fever and malaise may also occur in some instances
Diagnostic & Treatment
Diagnosis Path: Diagnosing this condition involves a combination of clinical evaluation and laboratory tests. These may include:
Treatment Protocols: Management of rapidly progressive glomerulonephritis focuses on controlling inflammation and preserving kidney function. Treatment approaches may include:
Clinical Advice & FAQs
Billing Guidance
Is N01.3 a billable ICD-10 code?
Yes, N01.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N01.3?
Clinical documentation must specify the nature of Rapidly progressive nephritic syndrome with diffuse mesangial proliferative glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
